GJA1 and colorectal carcinoma: Furthermore, the study of Zou ZW et al. revealed that Connexin43 (Cx43) gap junctions play a role in modulating CRC cells’ resistance to 5-FU, oxaliplatin, and irinotecan provide a potential basis for therapeutic strategies to overcome drug resistance in colon cancer [37].